We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current PTIX market cap is 6.1M. The company's latest EPS is USD -1.1274 and P/E is -1.22.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -924k | -656k | -739k | -1.14M | -1.43M |
Net Income | -925k | -602k | -718k | -1.21M | -1.4M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -2.09M | -2.55M | -4.14M | -3.56M | -4.53M |
Net Income | -1.75M | -2.55M | -4.52M | -3.56M | -5M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 8.25M | 8.04M | 7.67M | 6.92M | 5.43M |
Total Liabilities | 872k | 1.12M | 1.25M | 1.51M | 1.28M |
Total Equity | 7.38M | 6.92M | 6.41M | 5.41M | 4.15M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 842k | 879k | 11.06M | 8.04M | 4.32M |
Total Liabilities | 1.48M | 2.03M | 1.12M | 1.12M | 655k |
Total Equity | -634k | -1.15M | 9.94M | 6.92M | 3.67M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -1.81M | -1.99M | -372k | -1.9M | -2.56M |
Investing | 1.44M | 1.6M | 295k | 1.91M | 2.5M |
Financing | N/A | N/A | N/A | N/A | N/A |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -488k | -1.35M | -2.8M | -1.99M | -3.7M |
Investing | 250k | N/A | -9.91M | 1.6M | 4.78M |
Financing | 670k | 1.22M | 12.58M | N/A | N/A |
Market Cap | 6.1M |
Price to Earnings Ratio | -1.22 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 4.72 |
Price to Book Ratio | 1.66 |
Dividend Yield | - |
Shares Outstanding | 4.44M |
Average Volume (1 week) | 6.46k |
Average Volume (1 Month) | 9.71k |
52 Week Change | -26.08% |
52 Week High | 2.32 |
52 Week Low | 0.6797 |
Spread (Intraday) | 0.45 (26.32%) |
Company Name | Protagenic Therapeutics Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.protagenic.com |
Industry | books: pubg, pubg & printing (2731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions